102 related articles for article (PubMed ID: 16849373)
21. Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation.
Varani E; Guastaroba P; Di Tanna GL; Saia F; Balducelli M; Campo G; Vignali L; Rossi R; Manari A; Piovaccari G; De Palma R; Marzocchi A
EuroIntervention; 2010 Apr; 5(8):953-61. PubMed ID: 20542781
[TBL] [Abstract][Full Text] [Related]
22. The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial.
Zhang Z; Spertus JA; Mahoney EM; Booth J; Nugara F; Stables RH; Weintraub WS
Am Heart J; 2005 Jul; 150(1):175-81. PubMed ID: 16084166
[TBL] [Abstract][Full Text] [Related]
23. Impact of stents and abciximab on survival from cardiogenic shock treated with percutaneous coronary intervention.
Huang R; Sacks J; Thai H; Goldman S; Morrison DA; Barbiere C; Ohm J
Catheter Cardiovasc Interv; 2005 May; 65(1):25-33. PubMed ID: 15800889
[TBL] [Abstract][Full Text] [Related]
24. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial.
Cohen DJ; Bakhai A; Shi C; Githiora L; Lavelle T; Berezin RH; Leon MB; Moses JW; Carrozza JP; Zidar JP; Kuntz RE;
Circulation; 2004 Aug; 110(5):508-14. PubMed ID: 15262844
[TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of low-dose unfractionated heparin during percutaneous coronary revascularisation and the relationship between activated clotting time and haemorrhagic or ischaemic complications: our results.
Capuano C; Sesana M; Leonzi O; Cuccia C
J Cardiovasc Med (Hagerstown); 2006 Dec; 7(12):866-71. PubMed ID: 17122672
[TBL] [Abstract][Full Text] [Related]
26. The impact of the introduction of drug-eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease.
van Domburg RT; Lemos PA; Takkenberg JJ; Liu TK; van Herwerden LA; Arampatzis CA; Smits PC; Daemen J; Venema AC; Serruys PW; Bogers AJ
Eur Heart J; 2005 Apr; 26(7):675-81. PubMed ID: 15637087
[TBL] [Abstract][Full Text] [Related]
27. Clinical and economic outcomes of percutaneous coronary interventions in the elderly: an analysis of medicare claims data.
Clark MA; Bakhai A; Lacey MJ; Pelletier EM; Cohen DJ
Circulation; 2004 Jul; 110(3):259-64. PubMed ID: 15226211
[TBL] [Abstract][Full Text] [Related]
28. The impact of general usage of stents on short- and long-term health care costs following percutaneous coronary intervention.
Odell A; Landelius P; Astrom-Olsson K; Grip L
Cardiology; 2008; 109(2):85-92. PubMed ID: 17664872
[TBL] [Abstract][Full Text] [Related]
29. Influence of socioeconomic status on clinical outcomes and quality of life after percutaneous coronary intervention.
Denvir MA; Lee AJ; Rysdale J; Walker A; Eteiba H; Starkey IR; Pell JP
J Epidemiol Community Health; 2006 Dec; 60(12):1085-8. PubMed ID: 17108307
[TBL] [Abstract][Full Text] [Related]
30. Ambulatory transradial percutaneous coronary intervention: a safe, effective, and cost-saving strategy.
Le Corvoisier P; Gellen B; Lesault PF; Cohen R; Champagne S; Duval AM; Montalescot G; Elhadad S; Montagne O; Durand-Zaleski I; Dubois-Randé JL; Teiger E
Catheter Cardiovasc Interv; 2013 Jan; 81(1):15-23. PubMed ID: 22744871
[TBL] [Abstract][Full Text] [Related]
31. Acute and long-term cost implications of coronary stenting.
Peterson ED; Cowper PA; DeLong ER; Zidar JP; Stack RS; Mark DB
J Am Coll Cardiol; 1999 May; 33(6):1610-8. PubMed ID: 10334432
[TBL] [Abstract][Full Text] [Related]
32. Impact of an aggressive stenting strategy on initial and one-year follow-up costs in patients undergoing coronary angioplasty.
Farshid A; Leong B; Pitney M; McCredie RM; Allan R
Aust N Z J Med; 1999 Apr; 29(2):243-8. PubMed ID: 10342025
[TBL] [Abstract][Full Text] [Related]
33. [Ad-hoc coronary angioplasty: organizational model, clinical results and costs].
Varani E; Balducelli M; Lucchi GR; Vecchi G; Maresta A
Ital Heart J Suppl; 2002 Jun; 3(6):630-7. PubMed ID: 12116813
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness analysis of intravascular ultrasound guided percutaneous coronary intervention versus conventional percutaneous coronary intervention.
Gaster AL; Slothuus U; Larsen J; Thayssen P; Haghfelt T
Scand Cardiovasc J; 2001 Mar; 35(2):80-5. PubMed ID: 11405501
[TBL] [Abstract][Full Text] [Related]
35. Same day discharge after elective percutaneous coronary intervention.
Gilchrist IC
Curr Cardiol Rep; 2014 Apr; 16(4):470. PubMed ID: 24585111
[TBL] [Abstract][Full Text] [Related]
36. It's good to talk! Changes in coronary revascularisation practice in PCI centres without onsite surgical cover and the impact of an angiography video conferencing system.
Veasey RA; Hyde JA; Lewis ME; Trivedi UH; Cohen AC; Lloyd GW; Furniss SS; Patel NR; Sulke AN
Int J Clin Pract; 2011 Jun; 65(6):658-63. PubMed ID: 21564437
[TBL] [Abstract][Full Text] [Related]
37. Should use of intracoronary stents during percutaneous revascularisation be restricted?
Palmer N; Fort S; Starkey I; Shaw T; Northridge D
Lancet; 1998 Feb; 351(9100):416-7. PubMed ID: 9482299
[No Abstract] [Full Text] [Related]
38. Local provision of percutaneous coronary intervention increases stenting rates and reduces length of hospital stay in remote regional centre.
Bruce S; Smith JA; Atherton I; Leslie SJ
Rural Remote Health; 2013; 13(2):2136. PubMed ID: 23627289
[TBL] [Abstract][Full Text] [Related]
39. Impact of change in the price of percutaneous coronary intervention devices on medical expenses.
Kuroda N; Kobayashi Y; Desai K; Costantini C; Kobayashi M; Komuro I
Circ J; 2003 Jul; 67(7):576-8. PubMed ID: 12845178
[TBL] [Abstract][Full Text] [Related]
40. Trends in outcome and costs of coronary intervention in the 1990s.
Weintraub WS; Mahoney EM; Ghazzal ZM; King SB; Culler SD; Morris DC; Douglas JS
Am J Cardiol; 2001 Sep; 88(5):497-503. PubMed ID: 11524057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
